Ethos Technologies Inc. (LIFE)
Ethos Technologies will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Ethos Technologies Revenue
Ethos Technologies had revenue of $320.09M in the twelve months ending June 30, 2025. In the year 2024, Ethos Technologies had annual revenue of $254.93M with 59.57% growth.
Revenue (ttm)
$320.09M
Revenue Growth
+59.57%
P/S Ratio
n/a
Revenue / Employee
$649,266
Employees
493
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 254.93M | 95.17M | 59.57% |
| Dec 31, 2023 | 159.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLIFE News
- 18 days ago - Ethos Technologies Targets IPO Amid Positive Insurance Offerings - Seeking Alpha
- 22 days ago - Ethos Files Registration Statement for Proposed Initial Public Offering - GlobeNewsWire
- 2 months ago - Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors - GlobeNewsWire
- 1 year ago - aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” - GlobeNewsWire
- 1 year ago - aTyr Pharma to Present Poster Describing Efzofitimod's Mechanism of Action at the American Thoracic Society 2024 International Conference - GlobeNewsWire
- 1 year ago - aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis - GlobeNewsWire
- 1 year ago - aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - aTyr Pharma, Inc. (LIFE) Q4 2023 Earnings Call Transcript - Seeking Alpha